CRBP - Corbus Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRBP is currently covered by 2 analysts with an average price target of $367.56. This is a potential upside of $308.66 (524.04%) from yesterday's end of day stock price of $58.9.

Corbus Pharmaceuticals's activity chart (see below) currently has 9 price targets and 17 ratings on display. The stock rating distribution of CRBP is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 26.39% with an average time for these price targets to be met of 31.67 days.

Highest price target for CRBP is $22, Lowest price target is $22, average price target is $367.56.

Most recent stock forecast was given by JAMES EDWARDES JONES from RBC on 09-Aug-2023. First documented stock forecast 25-Oct-2016.

Currently out of the existing stock ratings of CRBP, 8 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

22

$-13 (-37.14%)

22

11 months 4 days ago

2/2 (100%)

$15.85 (257.72%)

216

Buy

3

$-47.31 (-94.04%)

3

1 years 4 months 4 days ago

2/2 (100%)

$0.48 (19.05%)

7

Hold

53.7

$3.39 (6.74%)

36.6

3 years 3 months 27 days ago

3/8 (37.5%)

$-14.4 (-21.15%)

62

Buy

690

3 years 10 months 5 days ago

0/1 (0%)

$483 (233.33%)

Hold

660

3 years 10 months 5 days ago

0/1 (0%)

$425.4 (181.33%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRBP (Corbus Pharmaceuticals) average time for price targets to be met?

On average it took 31.67 days on average for the stock forecasts to be realized with a an average price target met ratio 26.39

Which analyst has the current highest performing score on CRBP (Corbus Pharmaceuticals) with a proven track record?

JAMES EDWARDES JONES

Which analyst has the current lower performing score on CRBP (Corbus Pharmaceuticals) with a proven track record?

CHRISTOPHER MARAI

Which analyst has the most public recommendations on CRBP (Corbus Pharmaceuticals)?

James Edwardes Jones works at RBC and has 17 price targets and 11 ratings on CRBP

Which analyst is the currently most bullish on CRBP (Corbus Pharmaceuticals)?

Christopher Marai with highest potential upside - $953.26

Which analyst is the currently most reserved on CRBP (Corbus Pharmaceuticals)?

Andrew Fein with lowest potential downside - -$47.31

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?